Pfizer/BioNTech Seeks US FDA Approval for New COVID-19 Boosters for Children

Pfizer and its German partner BioNTech are asking the US Food and Drug Administration (FDA) to approve the new COVID-19 booster vaccine shots targeting the Omicron variant for school-age children. Pfizer and BioNTech submitted an application for emergency use authorization of their BA.4 and BA.5 focused bivalent vaccines for children between 5 to 11 years […]

Continue Reading

Pfizer Launched ‘An Accord for Healthier World’ to Improve Health Equity for People

Pfizer Inc., launched a new initiative called ‘An Accord for a Healthier World’. This initiative aims to provide all the patented, high-quality medicines, and vaccines of Pfizer available in the United States and European Union on a not-for-profit basis to 1.2 billion people in 45 lower-income countries. This initiative seeks to greatly decrease the health […]

Continue Reading